Aarey Drugs

24
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE198H01019
  • NSEID: AAREYDRUGS
  • BSEID: 524412
INR
76.43
-4.02 (-5.0%)
BSENSE

Dec 05

BSE+NSE Vol: 36.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024

Compare Profit and Loss Results of Aarey Drugs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
473.00
109.00
364.00
333.94%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
473.00
109.00
364.00
333.94%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
-3.00
-7.00
-233.33%
Raw Materials Consumed
472.00
100.00
372.00
372.00%
Power & Fuel Cost
0.00
6.00
-6.00
-100.00%
Employee Cost
0.00
6.00
-6.00
-100.00%
Operating Expenses
1.00
5.00
-4.00
-80.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
0.00
3.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
471.00
119.00
352.00
295.80%
Operating Profit (PBDIT) excl Other Income
2.00
-9.00
11.00
122.22%
Other Income
9.00
1.00
8.00
800.00%
Operating Profit (PBDIT)
12.00
-8.00
20.00
250.00%
Interest
4.00
1.00
3.00
300.00%
Profit before Depriciation and Tax
8.00
-10.00
18.00
180.00%
Depreciation
1.00
0.00
1.00
0%
Profit Before Taxation & Exceptional Items
6.00
-11.00
17.00
154.55%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-11.00
17.00
154.55%
Provision for Tax
2.00
-1.00
3.00
300.00%
Profit After Tax
4.00
-9.00
13.00
144.44%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
53.00
-63.00
116.00
184.13%
Profit Available for appropriations
57.00
-73.00
130.00
178.08%
Appropriations
57.00
-73.00
130.00
178.08%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.42
-2.69
4.11
152.79%
Profit And Loss - Net Sales
Net Sales 473.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024

Profit And Loss - Interest
Interest 4.66 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.02 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024